Home > Boards > US Listed > Biotechs >

Neptune tech and Bio-Resources (NEPT)

Add NEPT Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/23/2019 10:22:45 AM - Followers: 48 - Board type: Free - Posts Today: 0


I first heard about this stock when it was trading at the $2.32 mark a few weeks ago. Now we're hearing that more institutional buying and high profile firms are getting ready to take positions. That, in-turn, should lead to even more buying by retail investors. It's the stock snowball and visibility effect and this company deserves it 

About Neptune

Neptune Technologies & Bioressources Inc. researches, develops and commercializes proprietary bioactive ingredients and products with superior added-value and clinically proven health benefits. The Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune's first commercially available product is Neptune Krill Oil (NKO®), which represents the only clinically proven and scientifically acknowledged marine omega-3 phospholipids with cardiovascular, cognitive and anti-inflammatory benefits for human applications and which exhibits unmet safety, purity and stability and consequently denoting a new level of excellence in omega-3 standards.

Neptune is pursuing market opportunities in the nutraceutical market including dietary supplements and functional foods. The Company is benefiting from opportunities in the pharmaceutical market through its pharmaceutical subsidiaries Acasti Pharma and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

The Mission of Neptune is to:

  • Research, Develop and Commercialize Novel Marine Bioactive Ingredients
  • Pursue opportunities in the nutraceutical markets
    • Dietary Supplement
    • Functional Food
  • Exploit pharmaceutical applications
    • Subsidiary Acasti Pharma Inc: Cardiovascular diseases
    • Subsidiary NeuroBioPharm Inc.: Neurodegenerative diseases
  • Validate Superiority, Safety & Effectiveness
  • Protect Intellectual Property
  •   Enter Commercialization Alliances and Partnership Licenses

Promising results from A new cholesterol drug have helped call attention to Neptune, which is aiming for cholesterol/hyperlipidemia's ultimate prize, but unlike most companies dealing with clinical studies and regulatory approvals, Neptune is a revenue generating company whose products are already marketed and distributed in over 20 countries worldwide.

The Versant Partners' report, subtitled: "Krill oil franchise poised to outperform in multiple consumer and medical markets" features a few key points of note.

With NEPT's fiscal year end being February, Mr. Loe is calling for:

* F2012 revenues of $21.79 million and earnings $4.34 million ($0.09 EPS)
* F2013 revenues of $32.39 million and earnings of $8.81 million ($0.17 EPS)
* F2014 revenues of $45.37 million and earnings of $15.69 million ($0.30 EPS)
Loe cited management plans to meet forecasted demand by increasing current plant production from 130 thousand kilograms of krill oil per year to 430 thousand kilograms per year by 2015, a 300% production increase.
The report pinned its share price targets not only on the business Neptune has in hand, but also its future. By far, the biggest foundation Mr. Loe constructed on which to base his conclusions came from his meticulous research into the product itself - Neptune Krill Oil or NKO as it is branded on the market - and all its further refined products, such as Acasti's drug candidate called 'CaPre'.

Along the way, Loe also gives a significant nod to the functional food alliances Neptune developed with Yoplait - which is 50% owned by General Mills - and the food manufacturing behemoth, Nestle.

Mr. Loe wrote that both Yoplait and Nestle "should conclude development," of their research into Neptune Krill Oil by the end of the current year and that assuming all goes well, the sales of krill-oil infused food products by these giants would be a major revenue driver for Neptune in 2013/14  About Acasti

Acasti Pharma is developing safe and effective pharmaceutical and medical applications with an initial focus on cardiovascular disease by leveraging the intellectual property, clinical data and know how developed by Neptune Technologies. The Company is advancing a portfolio of bioactive ingredients of proprietary novel omega-3 phospholipids through the pharmaceutical development pathway which includes prescription medical foods (MF), over-the-counter products (OTC), and prescription drugs (Rx). Phospholipids are the major component of cell membranes and essential for all vital cell processes. They are one of the principle constituents of High Density Lipoprotein (good cholesterol) and play, as such, an important role in modulating cholesterol efflux.

Acasti Pharma's proprietary novel phospholipids carry and functionalize the polyunsaturated omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) stabilized by potent antioxidants. Evidence has demonstrated the anti-inflammatory properties of EPA and DHA regulating important biological functions including degenerative, arthritic, circulatory, digestive, and brain diseases. Delivering omega-3s functionalized on phospholipids helps optimize the omega-3 fatty acid therapeutic benefits. Potent antioxidants contribute to proper physiological regulation preventing free radical cellular damage, a common pathway for cardiovascular disease and inflammation as well as neurodegenerative disease 


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NEPT News: Report of Foreign Issuer (6-k) 05/13/2019 08:45:01 AM
NEPT News: Neptune accueille Martin Landry en tant que chef du développement et de la stratégie d'entreprise 05/13/2019 07:30:00 AM
NEPT News: Neptune Welcomes Martin Landry as Chief of Corporate Development & Strategy 05/13/2019 07:30:00 AM
NEPT News: Neptune Welcomes Martin Landry as Chief of Corporate Development & Strategy 05/13/2019 07:30:00 AM
NEPT News: Report of Foreign Issuer (6-k) 05/10/2019 08:04:51 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#385   Is plant in Conover NC a good deal? IPO$ 05/23/19 10:22:44 AM
#384   Chart looks good to me brandao 05/22/19 01:00:35 PM
#383   April’s Top Performing Cannabis Stocks RTupp23 05/12/19 02:31:48 PM
#382   Which CEO settled? Harland or Godin? Penelope Pringle 05/10/19 09:10:31 AM
#381   NEPT heating up watch her fly TrendTrade2016 05/03/19 04:52:35 AM
#380   https://www.newcannabisventures.com/cannabis-stocks-pause-in-april/ RavenStu52 05/03/19 12:00:43 AM
#379   NEPT thats why im a legend!! TrendTrade2016 04/25/19 04:24:53 AM
#378   NEPT.TO getting close to next wave. TrendTrade2016 04/24/19 05:12:32 AM
#377   $nept...$4.12...huge loading volume eod...on breakout alert.. chris20 04/22/19 03:53:08 PM
#376   $nept..$4.13...strong loading here...getting ready to run... chris20 04/22/19 03:03:03 PM
#375   $nept...huge bids just moved in to $4.13... chris20 04/22/19 11:48:41 AM
#374   $nept..$4.14..on the move... chris20 04/22/19 10:01:01 AM
#373   Jus loaded $nept..$4.11...strong chart breaking out... chris20 04/22/19 09:56:44 AM
#372   NEPT.TO is back and its furious. Put out TrendTrade2016 04/20/19 06:41:24 AM
#371   Well i mean they just got licensed to brandao 04/03/19 05:30:13 PM
#370   Nice and low float.... growth and revenues + brandao 04/03/19 05:28:34 PM
#369   I got a bunch of Aug $2 calls TheLastOneSitting 04/03/19 05:12:48 PM
#368   Hope so. Been in a while. fuzzychin 04/03/19 05:00:28 PM
#367   Taking a small position here ... and i brandao 04/03/19 02:41:45 PM
#366   We are very fortunate!!! Chipaway 03/26/19 12:00:02 PM
#365   Hard to believe this is still trading so low TheLastOneSitting 03/26/19 11:45:28 AM
#364   The quality of the extracts in Neptune's first Chipaway 03/26/19 11:41:30 AM
#363   https://finance.yahoo.com/news/neptune-begins-commercial-production-shipping-113 TheLastOneSitting 03/26/19 08:11:44 AM
#362   Boo Hiss!!! Chipaway 03/26/19 12:38:21 AM
#361   NEPT nailed in court by former CEO 236T568 03/25/19 05:11:04 PM
#360   dude, thanks, started reading on SA. interesting co. jammastermike 02/02/19 08:00:00 AM
#359   Neptune uses Solvent extraction (more pure). Everybody else Dude1967 02/01/19 11:31:12 PM
#358   I would jump over to StockTwits ( StockTwits Dude1967 02/01/19 11:24:47 PM
#357   what do you like about them? how challenging jammastermike 02/01/19 09:36:51 PM
#356   He was referring to the premarket price of Dude1967 02/01/19 03:27:31 PM
#355   i don't understand. can you elaborate? i'm thinking jammastermike 02/01/19 10:05:10 AM
#354   Strange behavior than i expected. I think crawford2012 02/01/19 09:36:37 AM
#353   hey crawford, what are referring to? jammastermike 02/01/19 08:34:40 AM
#352   Great news, big jump when the market opens crawford2012 02/01/19 06:46:42 AM
#351   Is this a canadian pot stock or a mjh4 01/07/19 10:15:07 AM
#350   Agreed. I am watching it now for Jaymeinnyc 01/07/19 09:45:25 AM
#349   " meant to grab on Thursday but thought jrf30 01/07/19 09:36:38 AM
#348   Dammit I meant to grab on Thursday but Jaymeinnyc 01/07/19 08:22:15 AM
#347   NEWS!! https://www.ftmig.com/cannabis/neptune-receives-license-to-process-cannab Jdoggg 01/07/19 07:58:05 AM
#346   Just got license approved friday. Fireworks tomorrow moneyjunkey 01/06/19 10:09:33 PM
#345   What's happening with this company? I just mjh4 01/05/19 08:34:04 PM
#344   So my 1 2 3 4 and 5 Scooter79 01/05/19 09:49:19 AM
#343   Yes is issued. Many deals to be announced. moneyjunkey 01/05/19 07:08:31 AM
#342   License granted today? I'm hearing rumors Scooter79 01/05/19 12:46:12 AM
#341   Thanks Dude1967 01/02/19 10:29:44 PM
#340   Stocktwits has a pretty good room Scooter79 01/02/19 10:22:08 PM
#339   Anybody here?? Dude1967 12/28/18 04:20:46 PM
#338   It's not, downward slide Scooter79 12/15/18 12:18:57 AM
#337   When’s the omega 3 patent and health Canada Tdogwm 11/12/18 08:58:59 AM
#336   40-F said 180 business days for DL from Yolo14 11/09/18 07:56:45 PM